Skip to main content
logo
BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
103.15
+0.45 (0.44%)
At close: Nov 28, 2025, 1:00 PM EST
100.50
-2.65 (-2.57%)
After-hours: Nov 28, 2025, 4:43 PM EST

Revenue Breakdown

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 2016 - 2020
COVID-19 Vaccine Revenue (Post-FY2023 Reporting)
2.26B2.43B
Log In
Log In
Log In
Upgrade
Other Sales Revenue (Post-FY2023 Reporting)
277.80M319.00M
Log In
Log In
Log In
Upgrade

Revenue Breakdown 2

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 2016 - 2020
COVID-19 Vaccine Revenue (Pre-FY2024 Reporting)
-
Log In
Log In
Log In
Upgrade
Other Sales Revenue (Pre-FY2024 Reporting)
-
Log In
Log In
Log In
Upgrade
Commercial Revenue
-
Log In
Log In
Log In
Upgrade
Research & Development Revenue
-
Log In
Log In
Log In
Upgrade
Updated Nov 3, 2025. Data Source: Fiscal.ai.